# Extracellular Vesicles: A Novel Approach to Mitigate Radiation-Induced Lung Damage

Canonical source: https://retacompare.com/research/extracellular-vesicles-a-novel-approach-to-mitigate-radiation-induced-lung-damage

Sinclair Lab Research · 2020-01-01


    Extracellular vesicles (EV) derived from human embryonic stem cells show promise in alleviating radiation-induced lung damage. This research, conducted by a team including Prof. David Sinclair from Harvard Medical School, investigates the therapeutic potential of these EVs in addressing normal tissue toxicity following ionizing radiation exposure. The findings suggest a significant impact on survival and lung health, which could have broader implications for longevity research.

 What this study examined

This study focused on the effects of human embryonic stem cell-derived extracellular vesicles on lung tissue damaged by ionizing radiation. Mice were subjected to high thoracic doses of radiation (14 Gy) to simulate radiation-induced lung injury. Following this, the researchers administered hESC-derived EVs systemically via the retro-orbital sinus to evaluate their therapeutic benefits. The primary outcomes measured included overall survival rates and the extent of lung fibrosis, assessed through imaging techniques and histological analyses.

 Why this matters for longevity research

The implications of this study extend into the realm of longevity research, particularly concerning the healthspan—the period during which individuals maintain good health. Radiation therapy, while effective for treating tumors, can lead to significant damage to surrounding healthy tissues, including the lungs. By demonstrating that hESC-derived EVs can improve survival and reduce lung fibrosis, this research highlights a potential avenue for enhancing healthspan in patients undergoing radiation therapy. Such advancements could contribute to overall longevity by mitigating the adverse effects of medical interventions.

 Key findings

Human embryonic stem cell-derived EVs significantly improved overall survival in irradiated mice (P < 0.001).

Treatment with EVs resulted in reduced lung fibrosis as quantified by CBCT imaging (P < 0.01, 2 weeks post-irradiation).

Histological analyses showed decreased signs of radiation-induced pulmonary injury in treated animals.

Proteomic analysis of EVs identified proteins related to nuclear pore complexes, epigenetics, and DNA repair.

EVs contained mitochondrial components, potentially aiding metabolic reprogramming in damaged lung tissue.

No adverse effects on tumor growth were observed in mice treated with EVs alongside tumor xenografts.

The findings suggest multiple mechanisms through which EVs may ameliorate radiation-induced tissue damage.

 The science behind it

The study's findings are situated within a broader context of aging and tissue regeneration research. The NAD+/sirtuin axis, a key player in cellular metabolism and longevity, is implicated in the response to cellular stress and damage. Extracellular vesicles may facilitate intercellular communication and transport bioactive molecules that enhance repair mechanisms. The presence of mitochondrial components within EVs suggests a role in metabolic reprogramming, which is crucial for recovery from injury. This aligns with the information theory of aging, which posits that maintaining cellular information integrity is vital for longevity.

 How it fits into the longevity field

This research contributes to a growing body of literature exploring the therapeutic potential of extracellular vesicles in various contexts, including aging and radiation therapy. Adjacent interventions, such as those targeting the sirtuin pathway or employing partial epigenetic reprogramming, may synergize with EV therapies to enhance tissue resilience and healthspan. The exploration of EVs as a treatment modality aligns with ongoing efforts to develop less invasive and more effective strategies for managing the side effects of cancer therapies.

 Practical takeaways

Researchers and clinicians should consider the potential of extracellular vesicles as a therapeutic strategy for mitigating radiation-induced damage. While the findings are promising, further studies are needed to elucidate the specific mechanisms at play and to evaluate the long-term effects of EV treatments. This research underscores the importance of exploring innovative approaches in the quest to extend healthspan and improve outcomes for patients undergoing radiation therapy.

 FAQ

 What are extracellular vesicles?

Extracellular vesicles are small membrane-bound particles released by cells that play a role in cell communication and can carry proteins, lipids, and nucleic acids.

 How do extracellular vesicles impact lung health?

In this study, extracellular vesicles derived from human embryonic stem cells were shown to reduce lung fibrosis and improve survival in mice exposed to radiation.

 What is the significance of this research for cancer patients?

This research suggests that extracellular vesicles could help mitigate the harmful effects of radiation therapy on healthy lung tissue, potentially improving patient outcomes.

 Source: PubMed · Front Oncol · published 2020-01-01.

## Sources

- PubMed · Front Oncol: https://pubmed.ncbi.nlm.nih.gov/33738245/